BIA
Benchmark Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $270K | Sell |
544
-69
| -11% | -$34.3K | 0.18% | 79 |
|
|
2024
Q4 | $319K | Sell |
613
-43
| -7% | -$22.4K | 0.21% | 71 |
|
|
2024
Q3 | $406K | Sell |
656
-900
| -58% | -$556K | 0.29% | 63 |
|
|
2024
Q2 | $861K | Sell |
1,556
-10
| -0.6% | -$5.53K | 0.62% | 40 |
|
|
2024
Q1 | $910K | Sell |
1,566
-374
| -19% | -$217K | 0.72% | 39 |
|
|
2023
Q4 | $1.03M | Sell |
1,940
-1,470
| -43% | -$780K | 0.95% | 33 |
|
|
2023
Q3 | $1.73M | Sell |
3,410
-207
| -6% | -$105K | 1.74% | 19 |
|
|
2023
Q2 | $1.89M | Buy |
3,617
+59
| +2% | +$30.8K | 1.74% | 17 |
|
|
2023
Q1 | $2.05M | Sell |
3,558
-107
| -3% | -$61.7K | 2.11% | 13 |
|
|
2022
Q4 | $2.02M | Sell |
3,665
-218
| -6% | -$120K | 2.13% | 13 |
|
|
2022
Q3 | $1.97M | Buy |
3,883
+31
| +0.8% | +$15.7K | 2.12% | 14 |
|
|
2022
Q2 | $2.09M | Buy |
3,852
+21
| +0.5% | +$11.4K | 2.18% | 11 |
|
|
2022
Q1 | $2.26M | Buy |
3,831
+1,591
| +71% | +$940K | 1.7% | 12 |
|
|
2021
Q4 | $1.5M | Buy |
+2,240
| New | +$1.5M | 1.23% | 26 |
|